Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer’s disease
Karsten Wicke, Andreas Haupt, Anton Bespalov
Expert Opinion on Investigational Drugs (2015) Vol. 24, Iss. 12, pp. 1515-1528
Closed Access | Times Cited: 39

Showing 26-50 of 39 citing articles:

Emerging amyloid and tau targeting treatments for Alzheimer’s disease
Ayesha Khan, Anne Corbett, Clive Ballard
Expert Review of Neurotherapeutics (2017) Vol. 17, Iss. 7, pp. 697-711
Closed Access | Times Cited: 13
Design and synthesis of novel N-sulfonyl-2-indoles that behave as 5-HT6 receptor ligands with significant selectivity for D3 over D2 receptors
Oscar M. Saavedra, Delphine Karila, Dominique Brossard, et al.
Bioorganic & Medicinal Chemistry (2016) Vol. 25, Iss. 1, pp. 38-52
Closed Access | Times Cited: 11
Procognitive profiling of a serotonin 5-HT6 receptor antagonist in a complex model system in rats: A novel translational approach for clinical prediction
István Gyertyán, Ferenc Kassai, Kata Kozma, et al.
Brain Research Bulletin (2020) Vol. 165, pp. 238-245
Open Access | Times Cited: 10
Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer’s Disease
Eunice D. Farfán‐García, Ricardo Márquez-Gómez, Mónica Barrón‐González, et al.
Current Alzheimer Research (2019) Vol. 16, Iss. 10, pp. 871-894
Closed Access | Times Cited: 9
Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease
Krzysztof Więckowski, Natalia Szałaj, Beata Gryzło, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9443-9443
Open Access | Times Cited: 5
Drug design of new 5-HT6R antagonists aided by artificial neural networks
Aldineia P. da Silva, Laise P. A. Chiari, Amanda Ribeiro Guimarães, et al.
Journal of Molecular Graphics and Modelling (2021) Vol. 104, pp. 107844-107844
Closed Access | Times Cited: 7
Drug design of new 5-HT6 antagonists: a QSAR study of arylsulfonamide derivatives
Aldineia P. da Silva, Rafaela Molina de Angelo, Heberth de Paula, et al.
Structural Chemistry (2020) Vol. 31, Iss. 4, pp. 1585-1597
Closed Access | Times Cited: 6
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
Xiaojiao Li, Lei Gao, Jingrui Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 6
Development and validation of sensitive LC–MS/MS method for the quantification of SUVN-502 and its metabolite and its application for first in human pharmacokinetic study
Ramakrishna Nirogi, Devender Reddy Ajjala, Raghupathi Aleti, et al.
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 145, pp. 423-430
Closed Access | Times Cited: 5
Mécanismes, facteurs de risque et stratégies thérapeutiques dans la maladie d’Alzheimer
Michel Maître, Christian Klein, Ayikoe Guy Mensah‐Nyagan
NPG. Neurologie, psychiatrie, gériatrie/NPG (2017) Vol. 17, Iss. 102, pp. 352-364
Closed Access | Times Cited: 3
Class A GPCR: Serotonin Receptors
Ellinor Grinde, Katharine Herrick‐Davis
Springer eBooks (2017), pp. 129-172
Closed Access | Times Cited: 1
Thiofunctionalization of Electron‐Rich Heteroarenes through Magnesiation and Trapping with Octasulfur
Gonzalo Vera, Reynald Mangeant, Silvia Stiebing, et al.
Advanced Synthesis & Catalysis (2021) Vol. 363, Iss. 22, pp. 5099-5105
Closed Access | Times Cited: 1
5-HT6 receptor antagonists. Design, synthesis, and structure–activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines
Michał Gałȩzowski, Charles‐Henry Fabritius, Ullamari Pesonen, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 96, pp. 129497-129497
Closed Access
Pro-cognitive effects of a AHN-208, 5-HT6 receptor antagonist, in the novel object recognition test in rats
Martyna Krawczyk, Adam S. Hogendorf, Adam S. Hogendorf, et al.
European Neuropsychopharmacology (2019) Vol. 29, pp. S148-S148
Closed Access
Previous Page - Page 2

Scroll to top